1–10 of 80 results for Ocular Oncology
Complex Ocular Oncology: Evolving Treatments in the Absence of Clinical Trials - 3 Decades Focused on Decreasing Treatment Related Morbidity/Mortality
Timothy G. Murray, MD, MBA, FASRS
Annual Meeting Talks
2020
Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
Using ‘Big Data’ to characterize uveal tumor treatment pathways and their complications in a cohort of commercially insured patients
Prithvi Mruthyunjaya, MD, MHS
On Demand Cases, Courses, and Papers
2019
Understanding the structural changes following photodynamic and transpupillary thermotherapy for choroidal hemangioma using OCT and OCT angiography.
VISHAL R RAVAL, MBBS, DNB, FMRF, FASRS
Incidence and features of uveal melanoma in a closed, managed care population
Michael Seider, MD
Eye Physics (EP) Plaques for Uveal Melanoma: Initial 12- and 24-month results in a private practice setting performed by a young surgeon
David A Reichstein, MD
Clinical presentation and outcomes of patients with isolated choroidal melanocytosis.
Zelia M. Correa, MD, PhD
Chorioretinal Vascular Side Effects of Intra-Arterial Chemotherapy for Retinoblastoma
Jose J Echegaray, MD
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Updates from the Field
2021
Ocular Oncology Symposium